Menu
GeneBe

rs757641323

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_025114.4(CEP290):c.451C>T(p.Arg151Ter) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000295 in 1,493,020 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000031 ( 0 hom. )

Consequence

CEP290
NM_025114.4 stop_gained

Scores

5
1
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:7

Conservation

PhyloP100: 5.86
Variant links:
Genes affected
CEP290 (HGNC:29021): (centrosomal protein 290) This gene encodes a protein with 13 putative coiled-coil domains, a region with homology to SMC chromosome segregation ATPases, six KID motifs, three tropomyosin homology domains and an ATP/GTP binding site motif A. The protein is localized to the centrosome and cilia and has sites for N-glycosylation, tyrosine sulfation, phosphorylation, N-myristoylation, and amidation. Mutations in this gene have been associated with Joubert syndrome and nephronophthisis and the presence of antibodies against this protein is associated with several forms of cancer. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 12-88131209-G-A is Pathogenic according to our data. Variant chr12-88131209-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 372761.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-88131209-G-A is described in Lovd as [Pathogenic]. Variant chr12-88131209-G-A is described in Lovd as [Likely_pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CEP290NM_025114.4 linkuse as main transcriptc.451C>T p.Arg151Ter stop_gained 7/54 ENST00000552810.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CEP290ENST00000552810.6 linkuse as main transcriptc.451C>T p.Arg151Ter stop_gained 7/541 NM_025114.4 P4

Frequencies

GnomAD3 genomes
AF:
0.0000134
AC:
2
AN:
149064
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000296
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000313
AC:
42
AN:
1343956
Hom.:
0
Cov.:
29
AF XY:
0.0000317
AC XY:
21
AN XY:
662596
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000301
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000377
Gnomad4 OTH exome
AF:
0.0000180
GnomAD4 genome
AF:
0.0000134
AC:
2
AN:
149064
Hom.:
0
Cov.:
32
AF XY:
0.0000138
AC XY:
1
AN XY:
72482
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000296
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000301
Hom.:
0
ExAC
AF:
0.00000874
AC:
1

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:3
Pathogenic, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Pathogenic, criteria provided, single submitterclinical testingGeneDxOct 11, 2016The R151X variant in the CEP290 gene has been reported previously in association with Leber congenital amaurosis, early-onset severe retinal dystrophy, and a nonspecified retinal dystrophy (Littink et al., 2010; Huang et al., 2015). This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The R151X variant was not observed in approximately 5,800 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Based on currently available evidence, we interpret R151X as a pathogenic variant. -
Pathogenic, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
not specified Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesJul 09, 2018The CEP290 c.451C>T;p.Arg151Ter variant has been described in at least one individual with retinal dystrophy (Huang 2015) and one family with early onset severe retinal dystrophy and Leber congential amaurosis (Littink 2010). The variant is listed in the ClinVar database (Variation ID: 372761) and the dbSNP variant database (rs757641323) but is not listed in the general population-based databases (Exome Variant Server, Genome Aggregation Database). The variant introduces a premature termination codon, but at least one report shows that this variant leads to a skipping of exon 7 or exon 7 and 8, which leads to an in-frame product lacking a portion of a functional domain. Considering available information, this variant is classified as likely pathogenic. References: Huang XF et al. Genotype-phenotype correlation and mutation spectrum in a large cohort of patients with inherited retinal dystrophy revealed by next-generation sequencing. Genet Med. 2015 Apr;17(4):271-8. Littink KW et al. A novel nonsense mutation in CEP290 induces exon skipping and leads to a relatively mild retinal phenotype. Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3646-52. -
Leber congenital amaurosis 10 Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingVictorian Clinical Genetics Services, Murdoch Childrens Research InstituteSep 02, 2022Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Joubert syndrome 5 (MIM#610188), Leber congenital amaurosis 10 (MIM#611755), Meckel syndrome 4 (MIM#611134) and Senior-Loken syndrome 6 (MIM#610189). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0209 - Variant proven to affect splicing of the transcript with uncertain effect on protein sequence. RT-PCR experiments using patient cDNA have demonstrated that this variant results in in-frame skipping of either exon 7 (p.(Leu148_Glu165del)) or exon 7 and exon 8 (p.(Leu148_Lys172del)) (PMIDs: 20130272, 28829391). (SP) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD <0.01 for a recessive condition (v3: 1 heterozygote, 0 homozygotes). (SP) 0604 - Variant is not located in an established domain, motif, hotspot or informative constraint region. (I) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been classified as likely pathogenic and pathogenic by multiple clinical diagnostic laboratories and has been reported as compound heterozygous in multiple individuals with Leber congenital amaurosis, early-onset severe retinal dystrophy or oligocone trichromacy (PMIDs: 20130272, 28829391, 25356976, 27208204). (SP) 1201 - Heterozygous variant detected in trans with a second pathogenic heterozygous variant (NM_025114.3(CEP290):c.2506G>T; p.(Glu836*)) in a recessive disease. (SP) 1205 - This variant has been shown to be maternally inherited (by segregation testing). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
Bardet-Biedl syndrome 14 Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingBaylor GeneticsOct 23, 2023- -
Meckel-Gruber syndrome;C0431399:Familial aplasia of the vermis;C0687120:Nephronophthisis Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingInvitaeOct 16, 2023This sequence change creates a premature translational stop signal (p.Arg151*) in the CEP290 gene. RNA analysis indicates that this premature translational stop signal induces altered splicing and likely results in a shortened protein product. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individuals with retinal dystrophy (PMID: 20130272, 25356976, 28829391; Invitae). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 372761). Studies have shown that this premature translational stop signal results in skipping of exon 7 or exons 7-8, but is expected to preserve the integrity of the reading-frame (PMID: 20130272). For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.63
D
BayesDel_noAF
Pathogenic
0.65
Cadd
Pathogenic
42
Dann
Uncertain
1.0
Eigen
Pathogenic
0.91
Eigen_PC
Pathogenic
0.79
FATHMM_MKL
Pathogenic
0.98
D
MutationTaster
Benign
1.0
A;A
Vest4
0.82
GERP RS
5.5

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.33
Details are displayed if max score is > 0.2
DS_AL_spliceai
0.33
Position offset: 9

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs757641323; hg19: chr12-88524986; API